EIRION THERAPEUTICS
Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. The company currently has a rich pipeline of products focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. In the future, Eirion plans to also pursue additional indications that address other major unmet clinical needs for physicians and their patients.
EIRION THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2016-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.eirionthera.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Register.com DNS Network Solutions Sun ONE Web Server Sun ONE Web Server V6.1
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Gore Range Capital
Gore Range Capital investment in Series A - Eirion Therapeutics
Haohai Biological Technology
Haohai Biological Technology investment in Series A - Eirion Therapeutics
Kinled Holding
Kinled Holding investment in Series A - Eirion Therapeutics
Official Site Inspections
http://www.eirionthera.com
- Host name: wf.networksolutions.com
- IP address: 205.178.189.131
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Eirion Therapeutics"
EIRIONTHERA.COM
Eirionthera offers innovative solutions for aesthetic medicine and medical dermatology.See details»
Eirion Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. …See details»
Eirion Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Www.eirionthera.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the Pipeline …See details»
Eirion Therapeutics, Inc. (Eirion Therapeutics, Inc.) - 药物管线_专 …
了解Eirion Therapeutics, Inc. (Eirion Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6项临床试验, 2篇新闻和1篇文献，技术平台:毒素，小分子化药，通用型CAR-T， …See details»
Eirion Company Profile 2024: Valuation, Funding & Investors
Eirion General Information Description. Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of wrinkles, primary axillary …See details»
Eirion Therapeutics - Craft
Eirion Therapeutics is a clinical-stage biopharmaceutical company developing prescription products for aesthetic dermatology. It mainly focuses on treatments for wrinkles, primary …See details»
Eirion Therapeutics Incorporated in Woburn, MA - (781) 935-1216
Eirion Therapeutics Incorporated is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Eirion Therapeutics Announces Strategic Agreement for HTL …
To learn more about Eirion: www.eirionthera.com . 2 About HTL HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A Investment …
Mar 9, 2021 Eirion's Clinical Product. Eirion's lead product ET-01 is a Phase 2 topical neuromodulator product candidate being developed for the treatment of lateral canthal lines …See details»
Eirion Therapeutics Announces Initiation of First-in-Human Clinical ...
Oct 17, 2022 Company Also Announces Update for Its Lead, Phase 2b Product Candidate Topical Neuromodulator ET-01. WOBURN, Mass., Oct. 17, 2022 /PRNewswire/ -- Eirion …See details»
Eirion Therapeutics Announces Strategic Agreement for HTL …
Sep 8, 2021 To learn more about Eirion: www.eirionthera.com. About HTL. HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical …See details»
Eirion Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.eirionthera.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the Pipeline …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A ... - Stem Cell
WOBURN, Mass., March 9, 2021 /PRNewswire/ --Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»
Eirion Therapeutics, Inc. Closes $40 Million Series A ... - BioSpace
WOBURN, Mass., March 9, 2021 /PRNewswire/ -- Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»
Eirion Therapeutics Announces Initiation of First-in-Human Clinical ...
WOBURN, Mass., July 1, 2024 /PRNewswire/ -- Eirion Therapeutics Inc. announced today that the first participant has been enrolled in a Phase 1 clinical trial to evaluate the safety of the …See details»
Eirion Therapeutics Announces Initiation of First-in-Human Clinical ...
Oct 17, 2022 Company Also Announces Update for Its Lead, Phase 2b Product Candidate Topical Neuromodulator ET-01. WOBURN, Mass., Oct. 17, 2022 /PRNewswire/ -- Eirion …See details»
Eirion Therapeutics Announces Initiation of First-in-Human Clinical ...
WOBURN, Mass., July 1, 2024 /PRNewswire/ -- Eirion Therapeutics Inc. announced today that the first participant has been enrolled in a Phase 1 clinical trial to evaluate the safety of the …See details»
Homepage | The LaRouche Organization
Dec. 3, 2024 (EIRNS)—“The central formal problem of contemporary knowledge is that the fact, which naïve opinion takes for the elementary or simple basis of human knowledge, proves …See details»
Eirion Therapeutics Announces Initiation of First-in-Human Clinical ...
WOBURN, MA, USA I July 1, 2024 I Eirion Therapeutics Inc. announced today that the first participant has been enrolled in a Phase 1 clinical trial to evaluate the safety of the patented …See details»
Priothera | Improving patient’s lives by delivering an innovative ...
We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic …See details»